Loading…

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

meRfi® AI Chat

NCT02708589 - Bifidobacterium breve + Bifidobacterium longum + Fructooligosaccharides (FOS) + Lacticaseibacillus casei + Lacticaseibacillus rhamnosus + Lactobacillus acidophilus + Lactobacillus delbrueckii bulgaricus + Streptococcus thermophilus vs Placebo (Maltodextrin) & Gastric Bypass / Roux-en-Y gastric bypass (RYGB) Surgery

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Background:

Bariatric surgery is recognized as one of the most effective methods for achieving sustainable weight loss. However, it can sometimes be linked to certain complications. This study was conducted to explore the impact of probiotic supplementation on various health issues associated with this type of surgery (1).

Study overview:

A placebo-controlled, double-blind, randomized clinical suppotive care trial evaluating [Bifidobacterium breve + Bifidobacterium longum + Fructooligosaccharides (FOS) + Lacticaseibacillus casei + Lacticaseibacillus rhamnosus + Lactobacillus acidophilus + Lactobacillus delbrueckii bulgaricus + Streptococcus thermophilus](brain://T2Arn4d7hUCXAA4S6DCkDg/Bif…

References (Sources)

Probiotic Supplementation in Morbid Obese Patients Undergoing One Anastomosis Gastric Bypass-Mini Gastric Bypass (OAGB-MGB) Surgery: a Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
Karbaschian et al. 2018 Clinical Trial Obes Surg. 28: 2874–2885

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!